MyFinsight
Home
Blog
About
Back
Income Statement
Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM)
source: myfinsight.com
Net loss
-$51,314K
(-6.96%↓ Y/Y)
US
$215,367K
(47.06%↑ Y/Y)
Non Us
$988K
(-60.68%↓ Y/Y)
Loss before income
taxes
-$51,186K
(-4.60%↓ Y/Y)
Income tax benefit
(expense)
$128K
(112.80%↑ Y/Y)
Product
$216,355K
(45.24%↑ Y/Y)
Non Us-Royalty And
Milestone Revenue
$2,020K
Loss from operations
-$49,646K
(-35.22%↓ Y/Y)
Interest expense, net
-$1,540K
(16.03%↑ Y/Y)
Revenue
$218,375K
(45.54%↑ Y/Y)
Total operating
expenses
$268,021K
(43.51%↑ Y/Y)
Gain in fair value of
contingent consideration
-$1,496K
(81.54%↑ Y/Y)
Selling, general and
administrative
$208,137K
(59.76%↑ Y/Y)
Research and development
$46,227K
(-6.69%↓ Y/Y)
Cost of revenue
(excluding amortization...
$13,564K
(0.86%↑ Y/Y)
Intangible asset
amortization
$1,589K
(0.00%↑ Y/Y)
Back